Cadherin 23 is a Prognostic Marker of Pancreatic Cancer and Promotes Cell Viability in Floating Culture Conditions

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2025 Jan 2

PMID 39744166

Authors

Chaohui Zhen

Peiwei Sun

Rui Liang

Shuang Fei

Xu Chen

Junlin Qian

Baoshi Xu

QiRui Lin

Guojun Yao

Biao Zheng

Affiliations

Soon will be listed here.

Abstract

: Pancreatic cancer has the worst prognosis of all common cancers worldwide. Cadherin plays important roles in cancer cell invasion and metastasis. This study investigated the role and mechanism of Cadherin 23 (CDH23) action in the viability of pancreatic cancer cells. : We examined CDH23 expression in 70 surgical pancreatic cancer samples and examined relationships among the level of CDH23 expression, clinicopathological characteristics, and the prognosis of the pancreatic cancer patients. Furthermore, we silenced CDH23 expression in pancreatic cancer cell lines (Panc-1, SUIT-2, MIA PaCa-2, CFPAC-1, and Capan-2) and assessed the viability of these cells. CDH23 expression in pancreatic cancer patients and cell lines was examined using immunohistochemistry and western blotting. : High levels of CDH23 in pancreatic cancer patients led to shorter overall survival and correlated with local recurrence and distance metastasis. The viability of pancreatic cancer cells in floating culture conditions decreased sharply when CDH23 was silenced. The viability and migration of pancreatic cancer cells in monolayer culture conditions did not change when CDH23 was silenced. The level of phosphorylated AKT was significantly decreased in the CDH23 knockdown cells in floating culture conditions. : High levels of CDH23 expression are correlated with a poor prognosis in pancreatic cancer and may serve as a novel prognostic marker.

References

Sannigrahi M, Srinivas C, Deokate N, Rakshit S . The strong propensity of Cadherin-23 for aggregation inhibits cell migration. Mol Oncol. 2019; 13(5):1092-1109. PMC: 6487693. DOI: 10.1002/1878-0261.12469. View

Zhang X, Tang N, Hadden T, Rishi A . Akt, FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011; 1813(11):1978-86. DOI: 10.1016/j.bbamcr.2011.03.010. View

Fidler I . The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-8. DOI: 10.1038/nrc1098. View

Santarosa M, Maestro R . The Autophagic Route of E-Cadherin and Cell Adhesion Molecules in Cancer Progression. Cancers (Basel). 2021; 13(24). PMC: 8699259. DOI: 10.3390/cancers13246328. View

Stemmler M . Cadherins in development and cancer. Mol Biosyst. 2008; 4(8):835-50. DOI: 10.1039/b719215k. View

Sommariva M, Gagliano N . E-Cadherin in Pancreatic Ductal Adenocarcinoma: A Multifaceted Actor during EMT. Cells. 2020; 9(4). PMC: 7226001. DOI: 10.3390/cells9041040. View

Saias L, Gomes A, Cazales M, Ducommun B, Lobjois V . Cell-Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation. Cancer Res. 2015; 75(12):2426-33. DOI: 10.1158/0008-5472.CAN-14-3534. View

Cao B, Guo X, Huang L, Wang B, Wang W, Han D . Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma. Aging (Albany NY). 2021; 13(13):17768-17788. PMC: 8312441. DOI: 10.18632/aging.203268. View

Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H . New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis. J Hepatol. 2010; 53(1):132-44. DOI: 10.1016/j.jhep.2010.02.027. View

10.

Yu M . Metastasis Stemming from Circulating Tumor Cell Clusters. Trends Cell Biol. 2019; 29(4):275-276. PMC: 7771971. DOI: 10.1016/j.tcb.2019.02.001. View

11.

Zhang Q, Peng C, Song J, Zhang Y, Chen J, Song Z . Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas. Am J Hum Genet. 2017; 100(5):817-823. PMC: 5420349. DOI: 10.1016/j.ajhg.2017.03.011. View

12.

Zheng B, Ohuchida K, Chijiiwa Y, Zhao M, Mizuuchi Y, Cui L . CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression. Mol Carcinog. 2015; 55(11):1560-1572. DOI: 10.1002/mc.22409. View

13.

Pereira-Veiga T, Schneegans S, Pantel K, Wikman H . Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance. Cell Rep. 2022; 40(9):111298. DOI: 10.1016/j.celrep.2022.111298. View

14.

Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

15.

Apostolopoulou M, Ligon L . Cadherin-23 mediates heterotypic cell-cell adhesion between breast cancer epithelial cells and fibroblasts. PLoS One. 2012; 7(3):e33289. PMC: 3296689. DOI: 10.1371/journal.pone.0033289. View

16.

Yang J, Lu F, Ma G, Pang Y, Zhao Y, Sun T . Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia. BMC Cancer. 2022; 22(1):568. PMC: 9123811. DOI: 10.1186/s12885-022-09532-1. View

17.

Onder T, Gupta P, Mani S, Yang J, Lander E, Weinberg R . Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008; 68(10):3645-54. DOI: 10.1158/0008-5472.CAN-07-2938. View

18.

Vanniya S P, Srisailapathy C, Kunka Mohanram R . The tip link protein Cadherin-23: From Hearing Loss to Cancer. Pharmacol Res. 2018; 130:25-35. DOI: 10.1016/j.phrs.2018.01.026. View

19.

Singaraju G, Sagar A, Kumar A, Samuel J, Hazra J, Sannigrahi M . Structural basis of the strong cell-cell junction formed by cadherin-23. FEBS J. 2019; . PMC: 7317872. DOI: 10.1111/febs.15141. View

20.

Zheng B, Ohuchida K, Cui L, Zhao M, Shindo K, Fujiwara K . TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells. Int J Oncol. 2015; 47(2):490-8. DOI: 10.3892/ijo.2015.3022. View